author-photo

Gary Meininger

Janssen Pharmaceutica

98

Papers

8444

Citations

Citation Trend

Filter By

Papers (65) Sort By

Journal Conference Others

Acute pancreatitis risk in type 2 diabetes patients treated with canagliflozin versus other antihyperglycemic agents: an observational claims database study.

2020 Current Medical Research and Opinion
Show All
- Source
- Cite
- Save
Citations (2)
1546-P: Acute Pancreatitis (AP) with Canagliflozin (CANA) vs. Other Antihyperglycemic Agents (AHAs): An Observational Study

2019 Diabetes
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 24: Diabetic Ketoacidosis in Patients with Type 2 Diabetes Treated with Sodium Glucose Co-transporter 2 Inhibitors versus Other Antihyperglycemic Agents: An Observational Study of Four US Administrative Claims Databases

2019 Circulation-cardiovascular Quality and Outcomes
Show All
- Source
- Cite
- Save
Citations (0)
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.

2019 The New England Journal of Medicine
Show All
- Source
- Cite
- Save
Citations (1785)
Achieving the composite endpoint of HbA1c, body weight, and systolic blood pressure reduction with canagliflozin in patients with type 2 diabetes

2018 Current Medical Research and Opinion
Show All
- Source
- Cite
- Save
Citations (4)
Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study–Renal (CANVAS‐R): A randomized, placebo‐controlled trial

2017 Diabetes, Obesity and Metabolism
Show All
- Source
- Cite
- Save
Citations (50)
Longer-term safety and tolerability of canagliflozin in patients with type 2 diabetes: a pooled analysis

2017 Current Medical Research and Opinion
Show All
- Source
- Cite
- Save
Citations (22)
Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study-Renal (CANVAS-R) : A randomized, placebo-controlled trial

2017 Diabetes, Obesity and Metabolism
Show All
- Source
- Cite
- Save
Citations (92)
Response to Comment on Erondu et al. Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program. Diabetes Care 2015;38:1680–1686

2016 Diabetes Care
Show All
- Source
- Cite
- Save
Citations (0)
Effects of Canagliflozin on Fracture Risk in Patients With Type 2 Diabetes Mellitus

2016 The Journal of Clinical Endocrinology and Metabolism
Show All
- Source
- Cite
- Save
Citations (257)